FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2094328405> ?p ?o ?g. }

• W2094328405 endingPage "597" @default.
• W2094328405 startingPage "590" @default.
• W2094328405 abstract "Rosiglitazone, an agonist of peroxisome proliferator–activated receptor-γ (PPARγ), is an insulin-sensitizing antidiabetic agent and inhibits restenosis in animal blood vessels. However, its benefit for patients with type 2 diabetes and coronary artery disease (CAD) after percutaneous coronary intervention is unknown. Patients with diabetes and CAD who had undergone percutaneous coronary intervention were randomized to either receive or not receive rosiglitazone (4 mg/d) for 6 months. After 6 months of rosiglitazone treatment, the plasma levels of fasting glucose and insulin and those of hemoglobin A1C and homeostasis model assessment of insulin resistance were significantly decreased in the rosiglitazone group as compared with baseline levels and those in the control group. After 2 and 6 months of rosiglitazone treatment, the plasma level of high-density lipoprotein was significantly increased in the rosiglitazone group. In addition, plasma levels of monocyte chemoattractant protein-1 and C-reactive protein and hyperresponsiveness of low-dose lipopolysaccharide-induced monocyte chemoattractant protein-1 secretion from monocytes were reduced. Furthermore, the occurrence of coronary events was significantly decreased in the rosiglitazone group at 6-month follow-up. Our data indicate that rosiglitazone may protect the vascular wall through not only improving the features of metabolic disorders but also reducing proinflammatory responses and the occurrence of coronary events in patients with diabetes and CAD after percutaneous coronary intervention." @default.
• W2094328405 created "2016-06-24" @default.
• W2094328405 creator A5011504948 @default.
• W2094328405 creator A5019859590 @default.
• W2094328405 creator A5021769901 @default.
• W2094328405 creator A5070369147 @default.
• W2094328405 creator A5083914493 @default.
• W2094328405 creator A5084139831 @default.
• W2094328405 date "2005-05-01" @default.
• W2094328405 modified "2023-10-17" @default.
• W2094328405 title "Peroxisome proliferator–activated receptor-γ agonist rosiglitazone reduces clinical inflammatory responses in type 2 diabetes with coronary artery disease after coronary angioplasty" @default.
• W2094328405 cites W1580962701 @default.
• W2094328405 cites W1583731895 @default.
• W2094328405 cites W1602835962 @default.
• W2094328405 cites W1873924216 @default.
• W2094328405 cites W1968787919 @default.
• W2094328405 cites W1974400848 @default.
• W2094328405 cites W1979804924 @default.
• W2094328405 cites W1986256219 @default.
• W2094328405 cites W1989619519 @default.
• W2094328405 cites W1991720779 @default.
• W2094328405 cites W1995130186 @default.
• W2094328405 cites W2011589019 @default.
• W2094328405 cites W2027208842 @default.
• W2094328405 cites W2086040049 @default.
• W2094328405 cites W2091736808 @default.
• W2094328405 cites W2102469433 @default.
• W2094328405 cites W2112546342 @default.
• W2094328405 cites W2116710893 @default.
• W2094328405 cites W2120549911 @default.
• W2094328405 cites W2123404136 @default.
• W2094328405 cites W2140372161 @default.
• W2094328405 cites W2153054296 @default.
• W2094328405 cites W2164367541 @default.
• W2094328405 cites W2168332555 @default.
• W2094328405 cites W2324841714 @default.
• W2094328405 cites W4240664509 @default.
• W2094328405 cites W4249862680 @default.
• W2094328405 cites W4251505062 @default.
• W2094328405 cites W4376542814 @default.
• W2094328405 cites W56664697 @default.
• W2094328405 doi "https://doi.org/10.1016/j.metabol.2004.11.017" @default.
• W2094328405 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15877288" @default.
• W2094328405 hasPublicationYear "2005" @default.
• W2094328405 type Work @default.
• W2094328405 sameAs 2094328405 @default.
• W2094328405 citedByCount "60" @default.
• W2094328405 countsByYear W20943284052012 @default.
• W2094328405 countsByYear W20943284052013 @default.
• W2094328405 countsByYear W20943284052014 @default.
• W2094328405 countsByYear W20943284052015 @default.
• W2094328405 countsByYear W20943284052017 @default.
• W2094328405 countsByYear W20943284052018 @default.
• W2094328405 countsByYear W20943284052020 @default.
• W2094328405 countsByYear W20943284052021 @default.
• W2094328405 countsByYear W20943284052022 @default.
• W2094328405 crossrefType "journal-article" @default.
• W2094328405 hasAuthorship W2094328405A5011504948 @default.
• W2094328405 hasAuthorship W2094328405A5019859590 @default.
• W2094328405 hasAuthorship W2094328405A5021769901 @default.
• W2094328405 hasAuthorship W2094328405A5070369147 @default.
• W2094328405 hasAuthorship W2094328405A5083914493 @default.
• W2094328405 hasAuthorship W2094328405A5084139831 @default.
• W2094328405 hasConcept C126322002 @default.
• W2094328405 hasConcept C134018914 @default.
• W2094328405 hasConcept C2777180221 @default.
• W2094328405 hasConcept C2777391703 @default.
• W2094328405 hasConcept C2778213512 @default.
• W2094328405 hasConcept C2780152017 @default.
• W2094328405 hasConcept C2780400711 @default.
• W2094328405 hasConcept C500558357 @default.
• W2094328405 hasConcept C555293320 @default.
• W2094328405 hasConcept C71924100 @default.
• W2094328405 hasConceptScore W2094328405C126322002 @default.
• W2094328405 hasConceptScore W2094328405C134018914 @default.
• W2094328405 hasConceptScore W2094328405C2777180221 @default.
• W2094328405 hasConceptScore W2094328405C2777391703 @default.
• W2094328405 hasConceptScore W2094328405C2778213512 @default.
• W2094328405 hasConceptScore W2094328405C2780152017 @default.
• W2094328405 hasConceptScore W2094328405C2780400711 @default.
• W2094328405 hasConceptScore W2094328405C500558357 @default.
• W2094328405 hasConceptScore W2094328405C555293320 @default.
• W2094328405 hasConceptScore W2094328405C71924100 @default.
• W2094328405 hasIssue "5" @default.
• W2094328405 hasLocation W20943284051 @default.
• W2094328405 hasLocation W20943284052 @default.
• W2094328405 hasOpenAccess W2094328405 @default.
• W2094328405 hasPrimaryLocation W20943284051 @default.
• W2094328405 hasRelatedWork W2037868476 @default.
• W2094328405 hasRelatedWork W2109371472 @default.
• W2094328405 hasRelatedWork W2351731829 @default.
• W2094328405 hasRelatedWork W2364632151 @default.
• W2094328405 hasRelatedWork W2378885292 @default.
• W2094328405 hasRelatedWork W2389042413 @default.
• W2094328405 hasRelatedWork W3028894677 @default.
• W2094328405 hasRelatedWork W3122076131 @default.
• W2094328405 hasRelatedWork W3186649432 @default.
• W2094328405 hasRelatedWork W4245156471 @default.

• next